We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Publisher Correction: Reclassification of therapeutic response of unresectable hepatocellular carcinoma to anti-angiogenic therapy and immunotherapy using alpha RECIST.
- Authors
Xu, Ying; Yang, Yi; Ouyang, Jingzhong; Zhou, Yanzhao; Li, Lu; Ye, Feng; Yang, Hongcai; Huang, Zhen; Zhou, Aiping; Zhang, Wen; Zhou, Jinxue; Zhao, Xinming; Zhao, Hong
- Abstract
This document is a correction notice for an article titled "Reclassification of therapeutic response of unresectable hepatocellular carcinoma to anti-angiogenic therapy and immunotherapy using alpha RECIST" published in the journal European Radiology. The correction addresses an error in the Graphical Abstract, specifically the deletion of the value "20" in typesetting. The corrected Graphical Abstract provides accurate information on the therapeutic response and prognostic stratification for hepatocellular carcinoma. The publisher, Springer Nature, maintains a neutral stance on jurisdictional claims and institutional affiliations.
- Subjects
NEOVASCULARIZATION inhibitors; HEPATOCELLULAR carcinoma; IMMUNOTHERAPY
- Publication
European Radiology, 2024, Vol 34, Issue 8, p5502
- ISSN
0938-7994
- Publication type
Correction Notice
- DOI
10.1007/s00330-023-10575-6